NLS Pharmaceutics Ltd (NLSP)
1.920
-0.46
(-19.33%)
USD |
NASDAQ |
Dec 20, 16:00
1.95
+0.03
(+1.57%)
After-Hours: 20:00
NLS Pharmaceutics Max Drawdown (5Y)
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| AC Immune SA | 89.55% |
| CRISPR Therapeutics AG | 81.61% |
| Addex Therapeutics Ltd | -- |
| Molecular Partners AG | -- |
| MoonLake Immunotherapeutics | -- |